Related Experiment Video
Updated: Jun 28, 2026
09:51
The Transition to an Anterior-Based Muscle Sparing Approach Improves Early Postoperative Function but is Associated with a Learning Curve
Published on: September 7, 2022
Administration of type A botulinum toxin after total hip replacement
M Bertoni1, A Castagna, A Baricich
1Neuromotor Rehabilitation Unit, MultiMedica IRCCS, Castellanza, Varese, Italy.
European Journal of Physical and Rehabilitation Medicine
|November 13, 2008
Summary
Botulinum toxin type A (BTX-A) injections effectively treated severe gluteal pain and functional loss after hip replacement. This approach resolved contractures, enabling full recovery when standard treatments failed.
Area of Science:
- Orthopedics
- Neurology
- Rehabilitation Medicine
Background:
- Post-hip replacement pain is a common rehabilitation challenge, often linked to persistent symptoms in patients with pre-existing hip arthritis.
- Severe pain and muscle contractures in the gluteal region can impede mobility and halt rehabilitation progress.
Observation:
- A female patient experienced debilitating gluteal pain post-total hip replacement (THR) for osteoarthritis, unresponsive to conventional therapies.
- This pain prevented upright posture and ambulation, leading to cessation of her rehabilitation program.
Findings:
- Injection of botulinum toxin type A (BTX-A) into the gluteus maximus muscle resulted in complete pain resolution and functional recovery.
- Follow-up assessments at 6 and 16 months confirmed sustained healing and restored function.
Implications:
- BTX-A demonstrates efficacy in treating painful, localized contractures, even without neurological deficits, offering a novel therapeutic option.
- Further research is warranted to optimize BTX-A dosage and administration protocols for similar cases.
Related Concept Videos
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:22Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...